Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide versus controlled-release carbamazepine monotherapy in newly or recently diagnosed epilepsy
2010-019765-28Phase 3Completed
- Sponsor
- UCB
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy and Epilepsy with generalized tonic-clonic seizures (GTCS) comparing Lacosamide monotherapy with Controlled-release carbamazepine monotherapy (2 arms). Primary endpoint: 6-month seizure freedom. Started Sep 2010; status: completed.
02
Drugs
lacosamidecarbamazepine
03
Conditions
epilepsyEpilepsy with generalized tonic-clonic seizures (GTCS)
Beyond the preview
Go deeper on 2010-019765-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019765-28.